Skip to main content
. Author manuscript; available in PMC: 2012 Jul 18.
Published in final edited form as: Vaccine. 2011 May 24;29(32):5276–5283. doi: 10.1016/j.vaccine.2011.05.013

Table 5.

Results of fertility studies

Antigen Immunization
route/(times)
Number of fertile
mice (%)
Mean #
embryos/mouse
rMOMP i.vag./col. (4X) 6/14 (43)a 2.0±2.9b
rMOMP i.n./s.l. (4X) 11/15 (73)a 4.9±4.0 b,c
rMOMP i.m./s.c. (4X) 14/21 (67)a 3.7±3.9b,c
rMOMP i.vag./col. (2X)
+ i.m./s.c. (2X)
17/21 (81)a,d 5.0±3.3b,c
rMOMP i.n./s.l. (2X)
+ i.m./s.c. (2X)
21/21 (100)d,e 6.0±3.0c,f,g
MoPn i.n. (1X) 21/21 (100)e 4.8±2.9b
Ng-rPorB i.m./s.c. (4X) 8/16 (50)a 3.0±3.8b,c
--- Fertility control 23/23 (100)d,e 7.2±3.0f
a

P<0.05 by the Fisher’s Exact test compared to the fertility control group.

b

P<0.05 by the Student’s t test compared to the fertility control group.

c

P>0.05 by the Student’s t test compared to the MoPn immunization group.

d

P>0.05 by the Fisher’s Exact test compared to the MoPn immunization group.

e

P<0.05 by the Fisher’s Exact test compared to the Ng-rPorB immunization group.

f

P<0.05 by the Student’s t test compared to the Ng-rPorB immunization group.

g

P>0.05 by the Student’s t test compared to the fertility control group.